← Back to Search

KIOS Informational App evaluation for Opioid Use Disorder (KIOS-I Trial)

N/A

Waitlist Available

Led By Jennifer Potter, Ph.D.

Research Sponsored by Biomedical Development Corporation

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up a user satisfaction survey will be administered at the end of one-week for participants enrolled in step 1 of the study and at the end of four-weeks for participants enrolled in step 2.

Awards & highlights

No Placebo-Only Group

Summary

This trial tests a smartphone app for opioid use disorder to provide drug info to people in recovery. It will confirm design and specs before a larger clinical trial.

Who is the study for?

This trial is for adults over 18 who are currently in an opioid treatment program and have been stable in their outpatient treatment for at least 4 weeks. Participants must be able to use the app on a smartphone or tablet. It's not for those unwilling to follow study rules, incarcerated individuals, pregnant women, or people with psychiatric or medical conditions that would hinder app usage.

What is being tested?

The trial is testing the KIOS Informational App designed to support self-management of opioid use disorder. The focus is on assessing how well the app works technically and whether it meets design specifications before a larger clinical trial evaluates its impact on health outcomes.

What are the potential side effects?

Since this study tests an informational app rather than a drug or medical procedure, traditional physical side effects are not expected. However, users may experience stress or discomfort from engaging with content about opioid recovery.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ a user satisfaction survey will be administered at the end of one-week for participants enrolled in step 1 of the study and at the end of four-weeks for participants enrolled in step 2.

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~a user satisfaction survey will be administered at the end of one-week for participants enrolled in step 1 of the study and at the end of four-weeks for participants enrolled in step 2.

This trial's timeline: 3 weeks for screening, Varies for treatment, and a user satisfaction survey will be administered at the end of one-week for participants enrolled in step 1 of the study and at the end of four-weeks for participants enrolled in step 2. for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.

Primary study objectives

Usability Score

Secondary study objectives

User Satisfaction

Awards & Highlights

No Placebo-Only Group

All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups

Experimental Treatment

Group I: KIOS Informational App evaluationExperimental Treatment1 Intervention

Study participants will use the app at least three times per week. The app will contain a user interface that includes a login page, true/false questions for the user to answer, verified public domain educational information about drug and alcohol use, Likert-type questions regarding the information presented, and a closing "Thank You" screen.

Do I qualify?Apply below to find out